Clinical significance of <i>MYCN</i> amplification in patients with high‐risk neuroblastoma

Abstract

MYCN amplification was associated with more aggressive features at diagnosis and a better early response, but a higher progression rate during induction treatment and lower chance of survival after relapse/progression. There was no difference in survival rates according to MYCN amplification in patients with high-risk NB.